Promoting Employee Health
While not uncommon before the COVID-19 pandemic, mental health issues have increased due to isolation, economic issues, and social upheaval, according to organizations like the National Institute of Mental Health.
This is bad news for employers. When employees bring these problems to the workplace, lost workdays can mean lost productivity. The National Safety Council’s cost calculator estimates that a manufacturing company in New Jersey with 250 employees could lose $284,504 annually because of missed workdays due to mental distress and illness.
Employers have options. For every $1 invested in the treatment and support of mental health disorders, an employer can see a return of $4 in improved health and productivity, according to estimates by The World Health Organization.
To promote employee mental health, employers can:
- Educate employees on the value of good mental health
- Offer employees telehealth access to providers through a laptop or cell phone.
- Train managers to support employees in understanding mental well-being
- Provide access to an employee assistance program (EAP) for referrals to mental health professionals.
To calculate what the costs of lost productivity to your workplace from mental health issues might be, visit www.nsc.org/mentalhealthatwork.
Copyright © 2020 Smarts Publishing
About the Author
Share This Story
Related Blogs
Fiduciary Responsibilities for Employer Health Plans: What Employers Should Know Now
When employers think about fiduciary responsibility, retirement plans often come to mind first. But recent developments make it clear that fiduciary duties also matter—sometimes significantly—when it comes to employer-sponsored health and welfare plans.
The New Era of Mental Health Parity Enforcement in 2026
Federal agencies have made mental health parity enforcement a top priority in 2026, and employers sponsoring group health plans are feeling the impact. Regulators are no longer satisfied with high‑level assurances that plans comply with the Mental Health Parity and Addiction Equity Act (MHPAEA). Instead, they expect detailed, data‑driven documentation showing that mental health and substance‑use‑disorder benefits are truly comparable to medical and surgical benefits. This includes not only the written plan design but also how rules are applied in real‑world scenarios.
The 2026 Specialty Drug Surge: What Employers Need to Prepare For
Specialty drugs have been a major cost driver for years, but 2026 marks a significant shift in both scale and urgency. With GLP 1 medications expanding into new indications, gene therapies entering the market at record pace, and oncology drugs continuing to rise in both cost and utilization, specialty medications are projected to account for more than 60% of total pharmacy spending this year. That’s a dramatic change for employers, especially considering that specialty drugs represent fewer than 5% of total prescriptions.